Chronotherapy for cancer

Biomedicine and Pharmacotherapy

Volumn 57, Issue SUPPL. 1, 2003, Pages 92-95

  Eriguchi, M ^a   Levi, F ^b   Hisa, T ^a   Yanagie, H ^a   Nonaka, Y ^c   Takeda, Y ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSERM   (France)

^c Department of Surgery   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer; Chronotherapy; Circadian rhythm; Clock genes; Liver metastases; Metastatic colorectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; OXALATO PLATINUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHRONOPHARMACOLOGY; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DRUG RESPONSE; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL;

EID: 0142200277     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.08.012     Document Type: Article

References (30)

1. Adam R., Avisar E., Ariche A., Giacchetti S., Azoulay D., Castaing D., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol. 8:2001;347-353.
2. Albrecht U., Sun Z.S., Eichele G., Lee C.C. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell. 91:1997;1055-1064.
3. Boughattas N.A., Levi F., Fournier C., Lemaigre G., Roulon A., Hecquet B., et al. Circadian rhythm in toxicities and tissue uptake of 1,2-diaminocyclehexane(trans-l)oxalatoplatinum(III) in mice. Cancer Res. 49:1989;3362-3368.
4. Eriguchi M., Fujii Y., Takeda Y., Yoshizaki I., Akiyama N., Shimizu H., et al. Chronotherapy: application to chemotherapy for gastric cancer and colorectal cancer. Oncologia. 25:1992;118-120.
5. Eriguchi M., Osada I., Fujii Y., Takeda Y., Yoshizaki I., Akiyama N., et al. Pilot study for preoperative administration of ℓ-OHP to patients with advanced scirrhous type gastric cancer. Biomed Pharmacother. 51:1997;217-220.
6. Eriguchi M., Nonaka Y., Yanagie H., Yoshizaki I., Takeda Y., Sekiguchi M. A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines. Biomed Pharmacother. 2003;. (in press).
7. Gayowski T.J., Iwatsuki S., Madariaga J.R., Selby R., Todo S., Irish W., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathological risk factors. Surgery. 116:1994;703-711.
8. Gekakis N., Staknis D., Nguyen H.B., Davis F.C., Wilsbacher L.D., King D.P., et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280:1998;1564-1569.
9. Giacchetti S., Itzhaki M., Gruia G., Adam R., Zidani R., Kunstlinger F., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-Fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 10:1999;663-669.
10. Halberg F., Stephens A.N. Susceptibility to ouabain and physiologic circadian periodicity. Proc Minn Acad Sci. 27:1959;139-143.
11. Halberg F., Haus E., Cardoso S.S., Scheving L.E., Kuhl J.F.W., Shiotsuka R., et al. Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms. Experientia. 29:1973;909-1044.
12. Haus E. Chronobiology of the mammalian response to ionizing radiation potential application in oncology. Chronobiol Int. 19:2002;77-100.
13. Hrushesky W.J.M., von Roemeling R., Lanning R.M., Rabatin J.T. Circadian-shaped infusion of floxuridine for progressive metastatic renal cell carcinoma. J Clin Oncol. 8:1990;1504-1513.
14. Ikeda M., Nomura M. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS protein (BMAL1) and identification of alternatively spliced variants with alternative translation initiation site usage. Biochem Biophys Res Commun. 233:1997;258-264.
15. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M., Antoch M.P., et al. Positional cloning of the mouse circadian clock gene. Cell. 89:1997;641-653.
16. Kobayashi M., Wood P.A., Hrushesky W.J.M. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int. 19:2002;237-251.
17. Levi F., Hrushesky W., Blomquist C.H., Lakatua D.J., Haus E., Halberg F., et al. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 42:1982;950-955.
18. Levi F. Chronobiology in oncology in 1987-1988. Adv Biosci. 73:1989;261-280.
19. Levi F., Zidani R., Misset J.L. Randomized multicentre trial of chemotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet. 350:1997;681-686.
20. Levi F. Chronopharmacology of anticancer agents. Redfern P., Lemmer B. Physiology and pharmacology of biological rhythms. 1997;299-331 Springer, Berlin.
21. Levi F. From circadian rhythms to cancer chronotherapeutics. Chronother Int. 19:2002;1-19.
22. Lowrey P.L., Shimomura K., Antoch M.P., Yamazaks S., Zemenides P.D., Ralph M.R., et al. Positional systemic cloning and functional characterization of the mammalian circadian mutation tau. Science. 288:2000;483-492.
23. Mathé G., Kidani Y., Sekiguchi M., Eriguchi M., Fredj G., Peytavin G., et al. Oxalato-platinum or ℓ-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum. Biomed Pharmacother. 43:1989;237-250.
24. Mormont M.C., Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer. 97:2003;155-169.
25. Okamura H., Miyake S., Sumi Y., Yamaguchi S., Yasui A., Muijtjens M., et al. Photic induction of mPer1 and mPer2 in Cry-deficient mice lacking a biological clock. Science. 286:1999;2531-2534.
26. Rees M., Plant G., Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg. 84:1997;1136-1140.
27. Sangoram A.M., Saez L., Antoch M.P., Gekakis N., Staknis D., Whiteley A., et al. Mammalian circadian autoregulatory loop: a timeless ortholog and mPER1 interact and negatively regulate CLOCK-BMAL1-induced transcription. Neuron. 21:1998;1101-1113.
28. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 77:1990;1241-1246.
29. Takumi T., Taguchi K., Miyake S., Sakakida Y., Takashima N., Matsubara C., et al. A light independent oscillatory gene mPer3 in mouse SCN and OVLT. EMBO J. 17:1998;4753-4759.
30. Tei H., Okamura H., Shigeyoshi Y., Fukuhara C., Ozawa K., Hirose M., et al. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature. 389:1997;512-516.